Fei Xue

1.8k total citations
67 papers, 1.3k citations indexed

About

Fei Xue is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Fei Xue has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Surgery and 14 papers in Cancer Research. Recurrent topics in Fei Xue's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (8 papers) and Extracellular vesicles in disease (8 papers). Fei Xue is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (8 papers) and Extracellular vesicles in disease (8 papers). Fei Xue collaborates with scholars based in China, United States and Italy. Fei Xue's co-authors include Deanna M. Janzen, Tingbo Liang, David A. Knecht, Liyang Dong, Xuefeng Wang, Xiao Zhi, Chao Liang, Xueli Bai, Yongbin Ma and Xin‐Hua Feng and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and Kidney International.

In The Last Decade

Fei Xue

65 papers receiving 1.3k citations

Peers

Fei Xue
Comparison fields: 5 of 117
  • Molecular Biology 750
  • Cancer Research 370
  • Surgery 190
  • Oncology 160
  • Immunology 149
Replace Pengfei Liu with:
Pengfei Liu China
Ze Zhang China
Giovanni Zito Italy
Xiaolong Xu China
Leilei Zhang China
Wenxin Song United States
Chek Kun Tan Singapore
Shun‐Fu Chang Taiwan
Mian Guo China
Pengfei Liu China View profile →
Citations per field, relative to Fei Xue
Fei Xue · 1×
Citations per year, relative to Fei Xue
Fei Xue · 1×

Countries citing papers authored by Fei Xue

Since Specialization
Citations

This map shows the geographic impact of Fei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Xue more than expected).

Fields of papers citing papers by Fei Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Xue. The network helps show where Fei Xue may publish in the future.

Co-authorship network of co-authors of Fei Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Xue. A scholar is included among the top collaborators of Fei Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Xue. Fei Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 9
3 5
4 156
5 13
6 16
7 7
8 22
9 7
10 16
11 7
12 17
13 38
14 30
15 15
16 1
17
Allergic rhinitis in women and the impact on incidence of allergic diseases in their offspring
1
18 12
19 7
20
The questionnaire survey of children allergic rhini-tis in Nanjing
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026